Using neuroimaging to predict relapse to smoking: Role of possible moderators and mediators

International Journal of Methods in Psychiatric Research

Volumn 17, Issue SUPPL. 1, 2008, Pages

  Schütz, Christian G ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Functional magnetic resonance imaging (fMRI); Mediators; Moderators; Neuroimaging; Smoking

Indexed keywords

ARTICLE; BRAIN REGION; BRAIN SCINTISCANNING; CHEMICAL CUE; EXPERIMENTAL ANIMAL; FUNCTIONAL MAGNETIC RESONANCE IMAGING; NEUROBIOLOGY; NEUROIMAGING; NONHUMAN; PROGNOSIS; RELAPSE; SENSITIVITY ANALYSIS; STIMULUS RESPONSE; STRESS; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; TRIGGER POINT; ATTENTION; BRAIN; ENVIRONMENT; HUMAN; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PROSPECTIVE STUDY; RECURRENT DISEASE; SMOKING; SMOKING CESSATION;

ATTENTION; BRAIN; ENVIRONMENT; HUMANS; MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDIES; RECURRENCE; SMOKING; SMOKING CESSATION;

EID: 50949110085     PISSN: 10498931     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpr.247     Document Type: Article

References (19)

1. Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances and inhalants: basic findings from the National Comorbidity Survey. Exp Clin Psychopharmacol 1994; 2: 244-68.
2. Birmingham K. What is translational medicine. Nat Med 2002; 8(7): 647. DOI: 10.1038/nm0702-647
3. Dani JA, Harris RA. Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nat Neurosci 2005; 8: 1465-70. DOI: 10.1038/ nn1580
4. DiFranza JR, Rigotti NA, McNeill AD. Initial symptoms of nicotine dependence in adolescents. Tob Control 2000; 9: 313-9.
5. Epstein DH, Preston KL. The reinstatement model and relapse prevention: a clinical perspective. Psychopharmacology 2003; 168(1-2): 31-41. DOI: 10.1007/s00213-003-1470-6
6. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160(4): 636-45.
7. Grant BF, Hasin DS, Chou SP, Stinson ES, Dawson DA. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2004; 61: 1107-15.
8. Landsberg MW, Scheef L, Daamen MM, Bludau J, Schildberg F, Bopp B, Johanson CE, Schütz CG. Cue-induced brain activation and relapse in smokers participating in a six months smoking cessation treatment program. A functional MRI study. Submitted for publication.
9. Miller NS, Gold MS. Dissociation of "conscious desire" (craving) from and relapse in alcohol and cocaine dependence. Ann Clin Psychiatry 1994; 6(2): 99-106.
10. O'Brien CR. A range of research-based pharmacotherapies for addiction. Science 1997; 278(5335): 66-70. DOI: 10.1126/science.278.5335.66
11. O'Brien CP, Gardner EL. Critical assessment of how to study addiction and its treatment: human and non-human animal models. Pharmacol Ther 2005; 108(1): 18-58. DOI: 10.1016/j.pharmthera.2005.06.018
12. Kraemer HC, Stice E, Kazdin A, Offord D, Kupfer D. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am J Psychiatry 2001; 158(6): 848-56.
13. McKay JR, Franklin TR, Patapis N, Lynch KG. Conceptual, methodological, and analytical issues in the study of relapse. Clin Psychol Rev 2006; 26(2): 109-27. DOI: 10.1016/j.cpr.2005.11.002
14. Schütz CG, Landsberg MW, Daamen M, Scheef L. Cue and stress induced brain activity changes and relapse in smokers. CPDD, Scottsdale AZ 17-22.06 2006 (abstract).
15. Shaham Y, Hope BT. The role of neuroadaptations in relapse to drug seeking. Nat Neurosci 2005; 8(11): 1437-9. DOI: 10.1038/nn1105-1437
16. Stewart J. Pathways to relapse: factors controlling the reinitiation of drug seeking after abstinence. Nebr Symp Motiv 2004; 50: 197-234.
17. Storr CL, Zhou H, Liang KY, Anthony JC. Empirically derived latent classes of tobacco dependence syndromes observed in recent-onset tobacco smokers: epidemiological evidence from a national probability sample survey. Nicotine Tob Res 2004; 6: 533-45. DOI: 10.1080/ 14622200410001696493
18. Vocci FJ, Acri J, Elkashef A. Medication development for addictive disorders: the state of the science. Am J Psychiatry 2005; 162(8): 1432-40.
19. World Health Organization (WHO). Tobacco or Health: A Global Status Report. Geneva: WHO, 1997.